[Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Schmiedeberg's Arch Pharmacol 2004;369:78-88.10.1007/s00210-003-0833-1]Search in Google Scholar
[Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.10.1038/35025203]Search in Google Scholar
[Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284-7.10.1038/28406]Search in Google Scholar
[Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. Fed Eur Biochem Soc Lett 1991;286:152-4.10.1016/0014-5793(91)80962-3]Search in Google Scholar
[Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001;21:542-7.10.1161/01.ATV.21.4.542]Search in Google Scholar
[Rodrigo L, Mackness B, Durrington PN, Hernandez A, Mackness MI. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem J 2001;354:1-7.10.1042/bj3540001]Search in Google Scholar
[Ahmed Z, Ravandi A, Maguire GF, Emili A, Draganov D, La Du BN, Kuksis A, Connelly PW. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. J Biol Chem 2001;276:24473-81.10.1074/jbc.M010459200]Search in Google Scholar
[Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275:3957-62.10.1074/jbc.275.6.3957]Search in Google Scholar
[Lund-Katz S, Liu L, Thuahnai ST, Phillips MC. High density lipoprotein structure. Front Biosci 2003;8: d1044-54.10.2741/1077]Search in Google Scholar
[Fuhrman B, Volkova N, Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 2002;161:307-16.10.1016/S0021-9150(01)00646-3]Search in Google Scholar
[Rozenberg O, Shih DM, Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler Thromb Vasc Biol 2003;23:461-7.10.1161/01.ATV.0000060462.35946.B3]Search in Google Scholar
[Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke S, La Du BN. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol 1999;19:2214-25.10.1161/01.ATV.19.9.2214]Search in Google Scholar
[Aharoni A, Gaidukov L, Yagur S, Toker L, Silman I, Tawfik DS. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci USA 2004;101:482-7.10.1073/pnas.2536901100]Search in Google Scholar
[Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004;11:412-9.10.1038/nsmb767]Search in Google Scholar
[Morales R, Berna A, Carpentier P, Contreras-Martel C, Renault F, Nicodeme M, Chesne-Seck ML, Bernier F, Dupuy J, Schaeffer C, Diemer H, Van-Dorsselaer A, Fontecilla-Camps JC, Masson P, Rochu D, Chabriere E. Discovery and crystallographic structure of human apolipoprotein. Ann Pharm 2000;65:98-107.10.1016/S0003-4509(07)90023-1]Search in Google Scholar
[Josse D, Ebel C, Stroebel D, Fontaine A, Borges F, Echalier A, Baud D, Renault F, Le Maire M, Chabriere E, Masson P. Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1). J Biol Chem 2002;277:33386-97.10.1074/jbc.M20010820012080042]Search in Google Scholar
[Rosenblat M, Gaidukov L, Khersonsky O, Vaya J, Oren R, Tawfik DS, Aviram M. The catalytic His dyad of High Density Lipoprotein-associated serum paraoxonase-I (PON1) is essential for PON1-mediated inhibition of Low Density Lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 2006;281:7657-66.10.1074/jbc.M51259520016407304]Search in Google Scholar
[Khersonsky O, Tawfik DS. The histidine-115 histidine-134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J Biol Chem 2006;281:7649-56.10.1074/jbc.M51259420016407305]Search in Google Scholar
[Kuo CL, La Du BN. Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 1995;23:935-44.]Search in Google Scholar
[Roodveldt C, Aharoni A, Tawfik DS. Directed evolution of proteins for heterologous expression and stability. Curr Opin Struct Biol 2005;15:50-6.10.1016/j.sbi.2005.01.00115718133]Search in Google Scholar
[Sekar K, Yu BZ, Rogers J, Lutton J, Liu X, Chen X, Tsai MD, Jain MK, Sundaralingam M. Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99. Biochemistry 1997;36:3104-14.10.1021/bi961576x9115986]Search in Google Scholar
[Scharff EI, Koepke J, Fritzsch G, Lucke C, Ruterjans H. Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. Structure (Camb) 2001;9:493-502.10.1016/S0969-2126(01)00610-4]Search in Google Scholar
[Waldo GS. Genetic screens and directed evolution for protein solubility. Curr Opin Chem Biol 2003;7:33-8.10.1016/S1367-5931(02)00017-0]Search in Google Scholar
[Roodveldt C, Tawfik DS. Directed evolution of phosphotriesterase from Pseudomonas diminuta for heterologous expression in Escherichia coli results in stabilization of the metal-free state. Protein Eng Des Sel 2005;18:51-583.10.1093/protein/gzi00515790580]Search in Google Scholar